A
Alfredo Mussi
Researcher at University of Pisa
Publications - 192
Citations - 7897
Alfredo Mussi is an academic researcher from University of Pisa. The author has contributed to research in topics: Lung cancer & Survival rate. The author has an hindex of 47, co-authored 192 publications receiving 7397 citations.
Papers
More filters
Journal ArticleDOI
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)
Riccardo Lencioni,Laura Crocetti,Roberto Cioni,Robert D. Suh,Derek Glenn,Daniele Regge,Thomas Helmberger,Alice Gillams,Andrea Frilling,Marcello Carlo Ambrogi,Carlo Bartolozzi,Alfredo Mussi +11 more
TL;DR: Percutaneous radiofrequency ablation yields high proportions of sustained complete responses in properly selected patients with pulmonary malignancies, and is associated with acceptable morbidity.
Journal Article
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Gabriella Fontanini,M. De Laurentiis,S Vignati,S. Chine,Marco Lucchi,V Silvestri,Alfredo Mussi,S. De Placido,Giampaolo Tortora,Ar Bianco,William J. Gullick,Carlo Alberto Angeletti,Generoso Bevilacqua,Fortunato Ciardiello +13 more
TL;DR: Evaluation of neoangiogenesis and of certain growth factors, such as AR, can be useful in addition to conventional pathological staging to select high-risk NSCLC patients who may benefit from post-surgical systemic therapies.
Journal ArticleDOI
Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study
Gabriella Fontanini,Marco Lucchi,S Vignati,Alfredo Mussi,Fortunato Ciardiello,M. De Laurentiis,S. De Placido,Fulvio Basolo,Carlo Alberto Angeletti,Generoso Bevilacqua +9 more
TL;DR: The relationship between tumor angiogenesis and survival for 407 patients with non-small-cell lung carcinoma who were treated with potentially curative surgery and in identifying subsets of patients who may benefit from different postsurgical treatments was evaluated.
Journal Article
Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
Gabriella Fontanini,S Vignati,Laura Boldrini,S. Chine,V Silvestri,Marco Lucchi,Alfredo Mussi,Carlo Alberto Angeletti,Generoso Bevilacqua +8 more
TL;DR: The hypothesis that VEGF is an important angiogenic factor in primary NSCLC and may help in predicting the outcome of this group of cancers is supported.
Journal ArticleDOI
Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
Bernard J. Park,Franca Melfi,Alfredo Mussi,Patrick Maisonneuve,Lorenzo Spaggiari,Ruy Kuenzer Caetano Da Silva,Giulia Veronesi +6 more
TL;DR: Robotic lobectomy for early-stage NSCLC can be performed with low morbidity and mortality and long-term stage-specific survival is acceptable and consistent with prior results for VATS and thoracotomy.